Abstract
In this work for the first time, in comparing with controls, the indicators that characterize dependence of hemolysis terms appearance on multiplicity of blood processing with nanoparticles MCS-B. It was found that extracorporeal blood treatment with MCS-B nanoparticles significantly reduces the activity of Ca, Mg-ATPase of erythrocytes. The performed researches confirm that with the help of nanoparticles of the MCS-B, it is possible not only to significantly reduce hemolysis, thereby extending the shelf life of the blood, but also to affect the activity of adenosine trisphosphatase of erythrocytes, to regulate the transmembrane exchange, and to affect extracorporarily the cellular apoptosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
